Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Essentialis reports results from phase IIb trial of DCCR

March 1, 2012

Potassium channel blocker has antiobesity effects in animal models

March 1, 2012

FDA revises labeling for statins

Feb. 29, 2012

FDA grants Repros meeting to discuss Androxal development

Feb. 28, 2012

Adocia's fast-acting human insulin comparable to NovoLog in phase IIa trial

Feb. 28, 2012

Novartis identifies novel acetyl-CoA carboxylase 2 inhibitors

Feb. 28, 2012

Watson Pharmaceuticals receives FDA complete response letter for vaginal gel

Feb. 28, 2012

Esmya approved in Europe

Feb. 27, 2012

Angiochem and GSK launch new collaboration

Feb. 27, 2012

Sirona Biochem assesses lead product in model of diabetes

Feb. 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...